Showing results (661-670 of 794) with videos related to

Sort By:
Pageof 80
Breast (Edinburgh, Scotland)|June 25, 2021
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort studyMatthew G Davey, Eoin Kerin, C O'Flaherty, et al.
The Journal of Urology|February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate CancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid TumorsChristopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Clinical Genitourinary Cancer|January 19, 2016
Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer CenterVinayak Muralidhar, Meredith M Regan, Lillian Werner, et al.
Scientific Reports|February 1, 2024
A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoringKate Connor, Emer Conroy, Kieron White, et al.
Nutrients|October 14, 2023
Vitamins and Minerals for Blood Pressure Reduction in the General, Normotensive Population: A Systematic Review and Meta-Analysis of Six SupplementsBenjamin J Behers, Julian Melchor, Brett M Behers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trialA A Hamid, H-C Huang, V Wang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 1, 1997
Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal modelsT J Carty, F J Sweeney, R J Griffiths, et al.
Annals of Surgical Oncology|June 29, 2007
Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional auditKatrina H Moore, Karl J Sweeney, Meaghan E Wilson, et al.
Pageof 80